ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing plateletsAndrew J. Souers, Steven W. Elmore, Sari H. Enschede et al.|Nature Medicine|2013Cited by 3k
Souers AJ, Leverson JD, Boghaert ER et al.ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19:202-208Andrew J. Souers, Steven W. Elmore, Erwin R. Boghaert et al.|Unknown|2013Cited by 182
Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule InhibitorGang Zhao, Philip R. Kym, Andrew J. Souers et al.|Journal of Medicinal Chemistry|2008Cited by 140
Identification and Preliminary Characterization of a Potent, Safe, and Orally Efficacious Inhibitor of Acyl-CoA:Diacylglycerol Acyltransferase 1Vince S. C. Yeh, Andrew J. Souers, David W. A. Beno et al.|Journal of Medicinal Chemistry|2012Cited by 34